Prostate cancer news reports: Friday, May 29, 2009

Today’s news reports address issues such as:

  • Pro-PSA (a pecursor molecule to PSA itself)
  • A review of development-stage markers for prostate cancer detection
  • Understanding the pathology report
  • A Phase I trial of high-dose testosterone in men with metatstatic CRPC … READ MORE …

The news report: Friday, April 10, 2009

Today’s news reports deal with:

  • A comparative, single institution study of RALP vs RRP
  • Bone mineral density and osteoporosis in men treated with intermittent hormone therapy
  • Transdermal testosterone therapy in men with castration-resistant prostate cancer

In a separate report we have discussed the development of a pre-biopsy risk assessment nomogram that incorporates results from PCA3 testing. … READ MORE …

Testosterone therapy for men with prostate cancer: is it good science AND good medicine?

The historic “prohibition” against the use of testosterone therapy in men with a history of prostate cancer is based on a model that assumes that the androgen sensitivity of prostate cancer extends throughout the range of testosterone concentrations. … READ MORE …